Literature DB >> 26069086

Radiation Dose to Patients from Radiopharmaceuticals: a Compendium of Current Information Related to Frequently Used Substances.

S Mattsson, L Johansson, S Leide Svegborn, J Liniecki, D Noßke, K Å Riklund, M Stabin, D Taylor, W Bolch, S Carlsson, K Eckerman, A Giussani, L Söderberg, S Valind.   

Abstract

This report provides a compendium of current information relating to radiation dose to patients, including biokinetic models, biokinetic data, dose coefficients for organ and tissue absorbed doses, and effective dose for major radiopharmaceuticals based on the radiation protection guidance given in Publication 60(ICRP, 1991). These data were mainly compiled from Publications 53, 80, and 106(ICRP, 1987, 1998, 2008), and related amendments and corrections. This report also includes new information for 82Rb-chloride, iodide (123I, 124I, 125I, and 131I) and 123I labeled 2ß-carbomethoxy 3ß-(4-iodophenyl)-N-(3-fluoropropyl) nortropane (FPCIT).The coefficients tabulated in this publication will be superseded in due course by values calculated using new International Commission on Radiation Units and Measurements/International Commission on Radiological Protection adult and paediatric reference phantoms and Publication 103 methodology (ICRP,2007). The data presented in this report are intended for diagnostic nuclear medicine and not for therapeutic applications.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26069086     DOI: 10.1177/0146645314558019

Source DB:  PubMed          Journal:  Ann ICRP        ISSN: 0146-6453


  60 in total

1.  Estimating cancer risk from 99mTc pyrophosphate imaging for transthyretin cardiac amyloidosis.

Authors:  Andrew J Einstein; Igor Shuryak; Adam Castaño; Akiva Mintz; Mathew S Maurer; Sabahat Bokhari
Journal:  J Nucl Cardiol       Date:  2018-05-30       Impact factor: 5.952

2.  Feasibility of dynamic stress 201Tl/rest 99mTc-tetrofosmin single photon emission computed tomography for quantification of myocardial perfusion reserve in patients with stable coronary artery disease.

Authors:  Sangwon Han; Young-Hak Kim; Jung-Min Ahn; Soo-Jin Kang; Jungsu S Oh; Eonwoo Shin; Changhwan Sung; Sun Young Chae; Seung-Jung Park; Gillan Grimberg; Gil Kovalski; Dae Hyuk Moon
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-06-02       Impact factor: 9.236

3.  Status of cardiovascular PET radiation exposure and strategies for reduction: An Information Statement from the Cardiovascular PET Task Force.

Authors:  James A Case; Robert A deKemp; Piotr J Slomka; Mark F Smith; Gary V Heller; Manuel D Cerqueira
Journal:  J Nucl Cardiol       Date:  2017-05-16       Impact factor: 5.952

4.  Finding sensitive parameters in internal dose calculations for radiopharmaceuticals commonly used in clinical nuclear medicine.

Authors:  Vladimir Spielmann; Wei Bo Li; Maria Zankl
Journal:  Radiat Environ Biophys       Date:  2018-06-29       Impact factor: 1.925

5.  Tc-99m pyrophosphate imaging for transthyretin cardiac amyloidosis: Importance of estimation of cancer risk with the modality.

Authors:  Shivda Pandey; Omar K Siddiqi
Journal:  J Nucl Cardiol       Date:  2018-07-27       Impact factor: 5.952

6.  Positron Emission Tomography Imaging of [11 C]Rosuvastatin Hepatic Concentrations and Hepatobiliary Transport in Humans in the Absence and Presence of Cyclosporin A.

Authors:  Sarah Billington; Steven Shoner; Scott Lee; Kindra Clark-Snustad; Matthew Pennington; David Lewis; Mark Muzi; Shirley Rene; Jean Lee; Tot Bui Nguyen; Vineet Kumar; Kazuya Ishida; Laigao Chen; Xiaoyan Chu; Yurong Lai; Laurent Salphati; Cornelis E C A Hop; Guangqing Xiao; Mingxiang Liao; Jashvant D Unadkat
Journal:  Clin Pharmacol Ther       Date:  2019-07-22       Impact factor: 6.875

7.  OpenDose: Open-Access Resource for Nuclear Medicine Dosimetry.

Authors:  Maxime Chauvin; Damian Borys; Francesca Botta; Pawel Bzowski; Jérémie Dabin; Ana M Denis-Bacelar; Aurélie Desbrée; Nadia Falzone; Boon Quan Lee; Andrea Mairani; Alessandra Malaroda; Gilles Mathieu; Erin McKay; Erick Mora-Ramirez; Andrew P Robinson; David Sarrut; Lara Struelens; Alex Vergara Gil; Manuel Bardiès
Journal:  J Nucl Med       Date:  2020-03-13       Impact factor: 10.057

8.  First-in-Human Studies of [18F] Fluorohydroxyphenethylguanidines.

Authors:  David M Raffel; Yong-Woon Jung; Robert A Koeppe; Keun Sam Jang; Guie Gu; Peter J H Scott; Venkatesh L Murthy; Jill Rothley; Kirk A Frey
Journal:  Circ Cardiovasc Imaging       Date:  2018-12       Impact factor: 7.792

9.  How to Provide Gadolinium-Free PET/MR Cancer Staging of Children and Young Adults in Less than 1 h: the Stanford Approach.

Authors:  Anne M Muehe; Ashok J Theruvath; Lillian Lai; Maryam Aghighi; Andrew Quon; Samantha J Holdsworth; Jia Wang; Sandra Luna-Fineman; Neyssa Marina; Ranjana Advani; Jarrett Rosenberg; Heike E Daldrup-Link
Journal:  Mol Imaging Biol       Date:  2018-04       Impact factor: 3.488

10.  Excretion of radionuclides in human breast milk after nuclear medicine examinations. Biokinetic and dosimetric data and recommendations on breastfeeding interruption.

Authors:  Sigrid Leide-Svegborn; Lars Ahlgren; Lennart Johansson; Sören Mattsson
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-01-06       Impact factor: 9.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.